CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-14 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −5,533 | $14.27 | $79K | 52,903 |
| 2022-02-14 | Galimi Francesco SVP & Chief Medical Officer | Grant or award | +16,000 | 65,450 | ||
| 2022-02-14 | Galimi Francesco SVP & Chief Medical Officer | Shares withheld for taxes | −5,533 | $14.27 | $79K | 59,917 |
| 2022-02-14 | Harvey Brian Nicholas Chief Financial Officer | Grant or award | +16,000 | 59,304 | ||
| 2022-02-14 | Harvey Brian Nicholas Chief Financial Officer | Shares withheld for taxes | −4,696 | $14.27 | $67K | 54,608 |
| 2022-02-14 | Schor Chen President & CEO | Grant or award | +48,000 | 170,712 | ||
| 2022-02-14 | Schor Chen President & CEO | Shares withheld for taxes | −21,288 | $14.27 | $304K | 149,424 |
| 2022-02-09 | Jakobovits Aya Director | Sale | −4,000 | $14.03 | $56K | 360,343 |
| 2022-02-09 | Jakobovits Aya Director | Sale | −4,000 | $14.03 | $56K | 360,345 |
| 2022-01-28 | Galimi Francesco SVP & Chief Medical Officer | Grant or award | +16,000 | 54,983 | ||
| 2022-01-28 | Galimi Francesco SVP & Chief Medical Officer | Shares withheld for taxes | −5,533 | $11.69 | $65K | 49,450 |
| 2022-01-28 | Healey Don Chief Technology Officer | Grant or award | +16,000 | 48,000 | ||
| 2022-01-28 | Healey Don Chief Technology Officer | Shares withheld for taxes | −5,533 | $11.69 | $65K | 42,467 |
| 2022-01-28 | Aftab Blake Chief Scientific Officer | Grant or award | +16,000 | 48,000 | ||
| 2022-01-28 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −5,564 | $11.69 | $65K | 42,436 |
| 2022-01-28 | Harvey Brian Nicholas Chief Financial Officer | Grant or award | +16,000 | 48,000 | ||
| 2022-01-28 | Harvey Brian Nicholas Chief Financial Officer | Shares withheld for taxes | −4,696 | $11.69 | $55K | 43,304 |
| 2022-01-28 | Schor Chen President & CEO | Grant or award | +48,000 | 144,000 | ||
| 2022-01-28 | Schor Chen President & CEO | Shares withheld for taxes | −21,288 | $11.69 | $249K | 122,712 |
| 2022-01-07 | Harvey Brian Nicholas Chief Financial Officer | Grant or award · Stock Option (Right to Buy | +125,000 | 125,000 |
Page 19 of 24 · 478 trades